Quick Read GLP-1 market growth is fueling Viking Therapeutics‘ (VKTX) momentum with VK2735 in Phase 3 and VK2809’s NASH ...

All this means that Viking is a great biotech buy -- its candidate is promising, you can benefit from getting in on the dip, and momentum has been picking up. But you don't have to rush to scoop up ...

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

Eli Lilly holds the lead position in the weight management market right now. But Viking Therapeutics is working on a candidate that could be a game-changer. Viking is a riskier-than-average stock, but ...

Viking Holdings (NYSE:VIK) just named nine new river ships at a ceremony in Basel, Switzerland. This marks its 100th vessel and solidifies its lead as the cruise line with the largest fleet. See our ...

The Viking Honir in Basel was one of nine river ships Viking welcomed into its fleet on Oct. 21, in ceremonies across six ...

The post Viking Cruises Just Reached 100 Ships — Here’s What That Means If You Love River Cruises appeared first on Travel ...